| Tinny Dohn, DO | |
|
50 E Hamilton Ave, # 100, Campbell, CA 95008-0259 | |
| (408) 364-7600 | |
| Not Available |
| Full Name | Tinny Dohn |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 50 E Hamilton Ave, Campbell, California |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710901285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A8202 (California) | Secondary |
| 207Q00000X | Family Medicine | 20A8202 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tinny Dohn, DO 2100 Powell St, Ste 900, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Tinny Dohn, DO 50 E Hamilton Ave, # 100, Campbell, CA 95008-0259 Ph: (408) 364-7600 |
News Archive
At the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), data were presented from a phase II investigator-sponsored trial paclitaxel poliglumex (Opaxio, CT-2103) in combination with capecitabine in first-line treatment of patients with metastatic breast cancer (MBC).
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5450(a)(1).
In her latest Kaiser Health News consumer column, Michelle Andrews writes, This summer, new health insurance programs aimed at people with preexisting medical conditions began accepting applications around the country.
iBio, Inc. confirmed today the grant of rights to use iBio's proprietary technology, the iBioLaunch™ platform, in support of a $5.3 million government-funded project for the development of a single vaccine to protect against both anthrax and plague. The project will be managed by Fraunhofer USA Center for Molecular Biotechnology (CMB) pursuant to the long-term agreement between iBio and CMB for advancement of the iBio technology.
› Verified 2 days ago
Elham J Louis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1580 Winchester Blvd, Ste 202, Campbell, CA 95008 Phone: 408-364-7600 | |
Christian James Fulmer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 E Hamilton Ave, Suite 120, Campbell, CA 95008 Phone: 408-995-5453 Fax: 408-275-9442 | |
Dr. Michelle Doscas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 E Hacienda Ave Ste B, Campbell, CA 95008 Phone: 408-376-3350 | |
Jeffrey Cheng-ta Peng, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 E Hamilton Ave Ste 120, Campbell, CA 95008 Phone: 408-357-1410 | |
Elvia Lily Cadena, PA Family Medicine Medicare: Medicare Enrolled Practice Location: 3425 S Bascom Ave Ste 200, Campbell, CA 95008 Phone: 408-356-5295 Fax: 408-356-5307 | |
Dr. Svetlana Dani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 E Hacienda Ave Ste B, Campbell, CA 95008 Phone: 408-376-3350 Fax: 408-374-4130 | |
Melanie Ann Martin, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 E Hamilton Ave, # 100, Campbell, CA 95008 Phone: 408-364-7600 |